Trial Profile
A Noninterventional Study of Vimpat (Lacosamide) as Adjunctive Antiepileptic Drug Therapy in Patients With Brain Tumor-related Epilepsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Apr 2020
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary) ; Antiepileptic drugs
- Indications Epilepsy; Partial epilepsies
- Focus Therapeutic Use
- Acronyms VIBES
- Sponsors UCB
- 01 Apr 2020 Result of a post hoc subgroup analyses were performed for patients with confirmed low-grade glioma were published in the Epilepsia
- 01 Apr 2020 Results published in the Epilepsia
- 05 Dec 2017 Status changed from active, no longer recruiting to completed.